Environment friendly supply of oncolytic enterovirus by provider cell line NK-92 Many members of the enterovirus household are thought-about as promising oncolytic brokers; nonetheless, their systemic administration is essentially inefficient as a result of fast neutralization of the…
Combining AFM13, a bispecific CD30/CD16 antibody
Combining AFM13, a bispecific CD30/CD16 antibody, with cytokine-activated cord blood-derived NK cells facilitates CAR-like responses against CD30+ malignancies Purpose: Natural killer (NK) cell recognition and function against NK-resistant cancers remains substantial barriers to the broad application of NK cell…